The DRI Fentanyl Assay is available in the United States for Criminal Justice and Forensic Use Only. This product is not intended for clinical diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae or patient management. The DRI Tricyclic Serum Tox Assay is 510(k) cleared in the United States.

About Ortho Clinical Diagnostics

Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 125 countries and territories, Ortho’s high-quality products and services enable health care professionals to make better-informed treatment decisions. Ortho brings sophisticated testing technologies, automation, and information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. For the immunohematology community, Ortho’s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho’s purpose is to improve and save lives with diagnostics, and it does that by reimagining what’s possible. This is what has defined Ortho for more than 75 years, and it’s what drives Ortho forward. 

1. For Criminal Justice and Forensic Use Only (US)

2. DEA Intelligence Brief. DEA-DCT-DIB-003-18. May 2018.

3. Jannetto, P. et. al. The Fentanyl Epidemic and Evolution of Fentanyl Analogs in the United States and the European Union. Clinical Chemistry 65:2, 242-253. 2019.

4. https://www.cihi.ca/en/opioids-in-canada/2018/opioid-related-harms-in-canada

5. TCA_Woolf_TCA - Evidence Based Consensus Guideline _Clin Tox_2008

Thermo Scientific and DRI are trademarks of Thermo Fisher Scientific and its subsidiaries.

PR-05445